{"id":"https://openalex.org/W2589074841","doi":"https://doi.org/10.1182/blood.v126.23.4530.4530","title":"The Impact of Time of Admission on the Delivery of Care and Outcomes in High Risk Patients with Acute Leukemia","display_name":"The Impact of Time of Admission on the Delivery of Care and Outcomes in High Risk Patients with Acute Leukemia","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2589074841","doi":"https://doi.org/10.1182/blood.v126.23.4530.4530","mag":"2589074841"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.4530.4530","doi":"https://doi.org/10.1182/blood.v126.23.4530.4530","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.4530.4530","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019444571","display_name":"Thomas Gregory Knight","orcid":"https://orcid.org/0000-0002-9864-7413","observed_orcids":["https://orcid.org/0000-0002-9864-7413"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Gregory Knight","raw_affiliation_strings":["University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040303721","display_name":"Joshua F. Zeidner","orcid":"https://orcid.org/0000-0002-9014-1514","observed_orcids":["https://orcid.org/0000-0002-9014-1514"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua F. Zeidner","raw_affiliation_strings":["Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065665275","display_name":"Naim U. Rashid","orcid":"https://orcid.org/0000-0002-7274-8259","observed_orcids":["https://orcid.org/0000-0002-7274-8259"]},"institutions":[{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naim U Rashid","raw_affiliation_strings":["Lineberger Comprehensive Cancer Center, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lineberger Comprehensive Cancer Center, Chapel Hill, NC","institution_ids":["https://openalex.org/I4390039329"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031561153","display_name":"Matthew Charles Foster","orcid":"https://orcid.org/0000-0002-6652-3838","observed_orcids":["https://orcid.org/0000-0002-6652-3838"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew C Foster","raw_affiliation_strings":["Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill,","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.32991563,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"126","issue":"23","first_page":"4530","last_page":"4530"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.28760001063346863,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.28760001063346863,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12174","display_name":"Hospital Admissions and Outcomes","score":0.28540000319480896,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11095","display_name":"Emergency and Acute Care Studies","score":0.23960000276565552,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-leukemia","display_name":"acute leukemia","score":0.8849999904632568},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9779999852180481},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":1.0},{"id":"https://openalex.org/keywords/time-of-admission","display_name":"time of admission","score":0.8619999885559082},{"id":"https://openalex.org/keywords/hyperleukocytosis","display_name":"hyperleukocytosis","score":0.8889999985694885},{"id":"https://openalex.org/keywords/hyperuricemia","display_name":"hyperuricemia","score":0.9909999966621399},{"id":"https://openalex.org/keywords/acute-promyelocytic-leukemia","display_name":"acute promyelocytic leukemia","score":0.9919999837875366},{"id":"https://openalex.org/keywords/hydroxyurea","display_name":"hydroxyurea","score":0.6639999747276306},{"id":"https://openalex.org/keywords/allopurinol","display_name":"allopurinol","score":0.9879999756813049},{"id":"https://openalex.org/keywords/rasburicase","display_name":"rasburicase","score":0.9850000143051147},{"id":"https://openalex.org/keywords/all-trans-retinoic-acid","display_name":"all-trans retinoic acid","score":0.8579999804496765},{"id":"https://openalex.org/keywords/time-to-chemotherapy","display_name":"time to chemotherapy","score":0.5289999842643738},{"id":"https://openalex.org/keywords/length-of-hospital-stay","display_name":"length of hospital stay","score":0.7179999947547913},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.7160000205039978},{"id":"https://openalex.org/keywords/high-risk-patients","display_name":"high-risk patients","score":0.4779999852180481},{"id":"https://openalex.org/keywords/cancer-care","display_name":"cancer care","score":0.3700000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9130988121032715},{"id":"https://openalex.org/C2778939600","wikidata":"https://www.wikidata.org/wiki/Q3088229","display_name":"Rasburicase","level":4,"score":0.5776494145393372},{"id":"https://openalex.org/C2776863199","wikidata":"https://www.wikidata.org/wiki/Q976388","display_name":"Acute leukemia","level":3,"score":0.5354580879211426},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.4994351863861084},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4657635986804962},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.45824381709098816},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4508299231529236},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.44720378518104553},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4373285174369812},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3989599645137787},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2227221131324768},{"id":"https://openalex.org/C2779788671","wikidata":"https://www.wikidata.org/wiki/Q998803","display_name":"Tumor lysis syndrome","level":3,"score":0.21271714568138123}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.4530.4530","doi":"https://doi.org/10.1182/blood.v126.23.4530.4530","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.4530.4530","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2525911130","https://openalex.org/W2742739529","https://openalex.org/W2891686832","https://openalex.org/W2907613291","https://openalex.org/W3105202461","https://openalex.org/W2072602077","https://openalex.org/W4383499021","https://openalex.org/W4280563511","https://openalex.org/W2146322615","https://openalex.org/W2952929485"],"abstract_inverted_index":{"Abstract":[0],"BACKGROUND:":[1],"At":[2],"a":[3,10,68,163],"large":[4],"academic":[5,445],"teaching":[6],"hospital,":[7,448],"there":[8,302],"are":[9],"variety":[11],"of":[12,20,26,28,38,71,74,100,104,124,127,157,183,203,207,314,376,394,400,431,434,437,439,497,502,521,542,598],"physicians":[13],"and":[14,23,55,63,78,135,190,211,240,276,321,331,341,383,397,509],"midlevel":[15],"providers":[16],"at":[17,76,443,499,547],"the":[18,24,72,125,175,269,298,390,408,418,427,432,435,500,519],"point":[19],"initial":[21],"contact,":[22],"extent":[25],"supervision":[27],"specifically":[29],"trained":[30],"oncology":[31],"personnel":[32],"may":[33,44,118,504],"vary":[34],"based":[35,97,311],"on":[36,98,312],"time":[37,99,182,199,308,313,322,332,343,436,461,478,501],"admission.":[39,101],"Patients":[40,213,545],"with":[41,46,87,112,130,148,249,256,280,319,329,351,474,523],"acute":[42,88,93,128,244,440,475,528],"leukemia":[43,90,95,129,246,441,529],"present":[45],"high":[47,83,109,217,293,299,362,470],"risk":[48,84,110,218,294,300,363,471],"disease":[49],"processes":[50],"that":[51,108],"must":[52],"be":[53,485],"recognized":[54],"require":[56],"prompt":[57],"intervention":[58,226,310],"to":[59,145,162,196,200,309,323,333,344,355,449,458,462,479,484,530],"reduce":[60],"both":[61],"morbidity":[62,134],"short-term":[64,136],"mortality.":[65,137],"This":[66,425],"is":[67,426],"retrospective":[69],"review":[70],"delivery":[73],"care":[75,532],"admission":[77,184,258,315,438,503],"key":[79,463],"clinical":[80,169,241,464,467],"outcomes":[81,194,251,468],"for":[82,152,243,254,361,407],"patients":[85,111,147,279,301,317,327,349,364,442,472,489,522],"presenting":[86,318,328,350],"myeloid":[89],"(AML)":[91],"or":[92,114,337,466,526],"lymphoblastic":[94],"(ALL)":[96],"The":[102],"hypothesis":[103],"this":[105,507,516],"study":[106],"was":[107,143,358,403,482],"AML":[113,567],"ALL":[115,575],"admitted":[116,161,365,473,490],"overnight":[117,257,366],"have":[119,505],"significant":[120,305],"delays":[121],"in":[122,133,284,307,342,348,469,488],"management":[123],"complications":[126],"subsequent":[131],"increases":[132],"METHODS:":[138],"An":[139],"institutional":[140],"electronic":[141,176],"database":[142],"queried":[144],"identify":[146],"ICD9":[149],"codes":[150],"specific":[151,191,197,225],"AML/ALL.":[153],"Inclusion":[154],"criteria":[155,223],"consisted":[156],"adults":[158],">18":[159],"years":[160],"single":[164],"institution":[165],"from":[166,174],"2010-2013.":[167],"Key":[168],"data":[170,517],"were":[171,214,252,266,282,290,303,513],"then":[172],"abstracted":[173],"medical":[177],"records":[178],"including":[179,316],"lab":[180],"values,":[181],"(Daytime:":[185],"7am-8pm":[186],"vs":[187],"Nightime:":[188],"8pm-7am),":[189],"clinically":[192],"important":[193],"(time":[195],"therapy,":[198],"chemotherapy,":[201],"length":[202,206,393,399],"stay,":[204,208],"ICU":[205,398,636],"organ":[209],"failure,":[210],"mortality).":[212],"categorized":[215],"as":[216,229,235,292,495,534,536],"if":[219],"they":[220],"met":[221],"established":[222],"requiring":[224],"[hyperleukocytosis":[227],"defined":[228,234],"WBC":[230],">50":[231],"10^9/L,":[232],"hyperuricemia":[233,330],"uric":[236],"acid":[237],">8":[238],"mg/dL,":[239],"suspicion":[242],"promyleocytic":[245],"(APL)].":[247],"Variables":[248],"binary":[250],"tested":[253,267],"association":[255],"using":[259,268],"Fisher's":[260],"exact":[261],"test.":[262,272],"All":[263],"other":[264],"variables":[265,493],"Wilcoxon":[270],"two-group":[271],"RESULTS:":[273],"Between":[274],"2010":[275],"2013,":[277],"161":[278],"AML/ALL":[281],"included":[283],"our":[285,450],"analysis.":[286],"Of":[287],"those,":[288],"66":[289,594],"classified":[291],"(Table":[295],"1).":[296],"In":[297],"no":[304],"differences":[306],"hyperleukocytosis":[320],"hydroxyurea":[324],"administration":[325,335,339,347],"(p=.32),":[326],"allopurinol":[334],"(p=.71)":[336],"rasburicase":[338],"(p=.22),":[340],"tretinoin":[345],"(ATRA)":[346],"APL":[352,572,587],"(p=.23).":[353],"Time":[354,607],"definitive":[356,480],"chemotherapy":[357,481],"significantly":[359,405,459,486],"less":[360,487],"(overnight":[367],"median=48":[368],"hours,":[369,372],"day":[370],"median=56":[371],"p=.042).":[373],"However,":[374],"rates":[375,512],"mechanical":[377],"ventilation":[378],"(p=.09),":[379],"vasopressor":[380],"usage":[381],"(p=.37),":[382],"renal":[384],"failure":[385],"(p=.43)":[386],"appeared":[387],"similar":[388],"between":[389,417],"groups.":[391,410],"Additionally,":[392],"stay":[395,401],"(p=.83)":[396],"(p=.44)":[402],"not":[404,414,456],"different":[406],"two":[409,419],"30-day":[411,510],"mortality":[412,511],"did":[413,455],"statistically":[415],"differ":[416],"groups":[420],"(overnight=19.4%,":[421],"daytime=20%,":[422],"p=.57).":[423],"CONCLUSIONS:":[424],"first":[428],"comprehensive":[429],"analysis":[430],"impact":[433,460],"an":[444],"tertiary":[446,531],"cancer":[447],"knowledge.":[451],"Interestingly,":[452],"nighttime":[453],"admissions":[454],"appear":[457],"interventions":[465],"leukemia.":[476],"Although":[477],"found":[483],"overnight,":[491],"confounding":[492],"such":[494],"severity":[496],"illness":[498],"impacted":[506],"analysis,":[508],"similar.":[514],"Overall,":[515],"supports":[518],"triage":[520],"newly":[524],"diagnosed":[525],"suspected":[527],"centers":[533],"soon":[535],"possible.":[537],"Table":[538],"1.":[539],"Baseline":[540],"Characteristics":[541],"High":[543,578,591],"Risk":[544,579,592],"Age":[546],"Diagnosis":[548,564],"Number":[549,565,600,608,622],"%":[550,566,601,609,623],"<50":[551],"31":[552],"47.0":[553],"50-64":[554],"24":[555],"36.3":[556],"65+":[557],"11":[558,576,637],"16.7":[559,577,638],"Sex":[560],"Male":[561],"38":[562],"57.6":[563],"(Excluding":[568],"APL)":[569],"37":[570],"56.1":[571],"18":[573,588],"27.2":[574,589],"Features":[580],"Hyperleukocytosis":[581],"42":[582],"63.6":[583],"Hyperuricemia":[584],"20":[585],"30.3":[586],">1":[590],"Feature":[593],"100.0":[595],"Initial":[596],"Point":[597],"Contact":[599],"Referring":[602],"Hospital":[603],"45":[604],"68.2":[605],"Admission":[606,620],"Day":[610],"Shift":[611,616],"(7a-8p)":[612],"30":[613],"45.5":[614],"Night":[615],"(8p-7a)":[617],"36":[618],"54.5":[619],"Location":[621],"Oncology":[624],"Inpatient":[625,631],"Service":[626,632],"53":[627],"80.3":[628],"Internal":[629],"Medicine":[630],"2":[633],"3.0":[634],"Medical":[635],"Disclosures":[639],"Foster:":[640],"Celgene:":[641],"Research":[642],"Funding.":[643]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2017-02-24T00:00:00"}